{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:06:29Z","timestamp":1756634789900,"version":"3.37.3"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"crossref","award":["MOST-108-2314-B-038-119-MY3"],"award-info":[{"award-number":["MOST-108-2314-B-038-119-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taipei Medical University\u2013Shuang Ho Hospital","award":["106TMU-SHH-06"],"award-info":[{"award-number":["106TMU-SHH-06"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227571","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T13:52:03Z","timestamp":1578664323000},"page":"e0227571","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study"],"prefix":"10.1371","volume":"15","author":[{"given":"Nen-Chung","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Tai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jui","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Tai","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-7523","authenticated-orcid":true,"given":"Ming-Yow","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"key":"pone.0227571.ref001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"EZ Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"pone.0227571.ref002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cjca.2011.12.011","article-title":"Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation","volume":"28","author":"Global Registry of Acute Coronary Events (GRACE\/GRACE2) and the Canadian Registry of Coronary Events (CANRACE) Investigators","year":"2012","journal-title":"Can J Cardiol"},{"key":"pone.0227571.ref003","doi-asserted-by":"crossref","first-page":"e003347","DOI":"10.1161\/JAHA.116.003347","article-title":"Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms","volume":"5","author":"F Violi","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"pone.0227571.ref004","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1253\/circj.CJ-11-0378","article-title":"One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE)","volume":"75","author":"J-TRACE Investigators","year":"2011","journal-title":"Circ J"},{"key":"pone.0227571.ref005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.108.804203","article-title":"Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial","volume":"119","author":"J Aoki","year":"2009","journal-title":"Circulation"},{"key":"pone.0227571.ref006","doi-asserted-by":"crossref","first-page":"e0214417","DOI":"10.1371\/journal.pone.0214417","article-title":"Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock","volume":"14","author":"CT Mao","year":"2019","journal-title":"PLoS One"},{"key":"pone.0227571.ref007","doi-asserted-by":"crossref","first-page":"e0147245","DOI":"10.1371\/journal.pone.0147245","article-title":"Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention","volume":"11","author":"A Sambola","year":"2016","journal-title":"PLoS One"},{"key":"pone.0227571.ref008","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)","volume":"48","author":"European Heart Rhythm Association","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"pone.0227571.ref009","first-page":"e1","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"pone.0227571.ref010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"pone.0227571.ref011","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"WOEST study investigators","year":"2013","journal-title":"Lancet"},{"key":"pone.0227571.ref012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2014.10.016","article-title":"Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome","volume":"135","author":"O\u00d6 Braun","year":"2015","journal-title":"Thromb Res"},{"key":"pone.0227571.ref013","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"CT January","year":"2019","journal-title":"Circulation"},{"key":"pone.0227571.ref014","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI","volume":"375","author":"CM Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0227571.ref015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation","volume":"377","author":"RE-DUAL PCI Steering Committee and Investigators","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0227571.ref016","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.118.034722","article-title":"Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention","volume":"138","author":"DJ Angiolillo","year":"2018","journal-title":"Circulation"},{"key":"pone.0227571.ref017","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"PT O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"pone.0227571.ref018","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCINTERVENTIONS.111.965186","article-title":"Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary","volume":"4","author":"DP Faxon","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0227571.ref019","first-page":"e44","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"American College of Cardiology Foundation","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"pone.0227571.ref020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004395","article-title":"Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update","volume":"9","author":"DJ Angiolillo","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0227571.ref021","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","author":"GY Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"pone.0227571.ref022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12872-017-0500-y","article-title":"Gender based differences in drug eluting stent implantation\u2014data from the German ALKK registry suggest underuse of DES in elderly women","volume":"17","author":"ALKK-Study Group","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0227571.ref023","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/clc.20000","article-title":"A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions","volume":"30","author":"C Kim","year":"2007","journal-title":"Clin Cardiol"},{"key":"pone.0227571.ref024","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","article-title":"Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database","volume":"175","author":"AW Hsing","year":"2015","journal-title":"JAMA Intern Med"},{"key":"pone.0227571.ref025","doi-asserted-by":"crossref","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","article-title":"Data resource profile: the National Health Insurance Research Database (NHIRD)","volume":"40","author":"LY Lin","year":"2018","journal-title":"Epidemiol Health"},{"key":"pone.0227571.ref026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan\u2019s National Health Insurance Research Database: past and future","volume":"11","author":"CY Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"key":"pone.0227571.ref027","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of acute myocardial infarction cases in the national health insurance research database in taiwan","volume":"24","author":"CL Cheng","year":"2014","journal-title":"J Epidemiol"},{"key":"pone.0227571.ref028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijcard.2016.04.014","article-title":"Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction","volume":"215","author":"DY Chen","year":"2016","journal-title":"Int J Cardiol"},{"key":"pone.0227571.ref029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","article-title":"Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database","volume":"114","author":"CY Hsieh","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"pone.0227571.ref030","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"CY Wu","year":"2012","journal-title":"JAMA"},{"key":"pone.0227571.ref031","unstructured":"Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL, et al; for Standardized Data Collection for Cardiovascular Trials Initiative. Standardized Definitions for End Point Events in Cardiovascular Trials. US Food & Drug Administration. 2010."},{"key":"pone.0227571.ref032","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1253\/circj.CJ-15-0778","article-title":"Clinical Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Acute Myocardial Infarction Patients Under Dialysis\u2014A Nationwide Cohort Study","volume":"80","author":"DY Chen","year":"2016","journal-title":"Circ J"},{"key":"pone.0227571.ref033","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.107.188208","article-title":"2007 Focused Update of the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee","volume":"117","author":"2005 WRITING COMMITTEE MEMBERS","year":"2008","journal-title":"Circulation"},{"key":"pone.0227571.ref034","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2009.10.003","article-title":"Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)","volume":"2","author":"TAXUS IV Investigators","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"pone.0227571.ref035","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"SCAAR Study Group","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0227571.ref036","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"EP McFadden","year":"2004","journal-title":"Lancet"},{"key":"pone.0227571.ref037","first-page":"611","article-title":"Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"172","author":"Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation","year":"2012","journal-title":"Arch Intern Med"},{"key":"pone.0227571.ref038","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"ACC\/AHA Task Force Members","year":"2014","journal-title":"Circulation"},{"key":"pone.0227571.ref039","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"pone.0227571.ref040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.thromres.2014.01.007","article-title":"CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"133","author":"MK Puurunen","year":"2014","journal-title":"Thromb Res"},{"key":"pone.0227571.ref041","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"ZEUS Investigators","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"pone.0227571.ref042","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk","volume":"373","author":"LEADERS FREE Investigators","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0227571.ref043","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","article-title":"Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial","volume":"391","author":"SENIOR investigators","year":"2018","journal-title":"Lancet"},{"key":"pone.0227571.ref044","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"RG Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"pone.0227571.ref045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/clc.22898","article-title":"Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT\u2014Atrial Fibrillation study) multicenter registry","volume":"41","author":"BJ Potter","year":"2018","journal-title":"Clin Cardiol"},{"key":"pone.0227571.ref046","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12471-018-1113-5","article-title":"Optimal duration of dual antiplatelet therapy for coronary artery disease","volume":"26","author":"WJ Kikkert","year":"2018","journal-title":"Neth Heart J"},{"key":"pone.0227571.ref047","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cjca.2012.08.008","article-title":"Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation","volume":"29","author":"KW Ho","year":"2013","journal-title":"Can J Cardiol"},{"key":"pone.0227571.ref048","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc12-1507","article-title":"Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation","volume":"36","author":"DESERT cooperation","year":"2013","journal-title":"Diabetes Care"},{"key":"pone.0227571.ref049","doi-asserted-by":"crossref","first-page":"e15070","DOI":"10.1371\/journal.pone.0015070","article-title":"Drug-eluting stents in patients with chronic kidney disease: a prospective registry study","volume":"5","author":"C Shenoy","year":"2010","journal-title":"PLoS One"},{"key":"pone.0227571.ref050","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/00029330-200607020-00007","article-title":"Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention","volume":"119","author":"RY Zhang","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"pone.0227571.ref051","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCINTERVENTIONS.108.828954","article-title":"The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era","volume":"2","author":"CE Appleby","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"pone.0227571.ref052","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1253\/circj.CJ-15-0778","article-title":"Clinical Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Acute Myocardial Infarction Patients Under Dialysis\u2014A Nationwide Cohort Study","volume":"80","author":"DY Chen","year":"2016","journal-title":"Circ J"},{"key":"pone.0227571.ref053","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.ijcard.2013.03.046","article-title":"Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation","volume":"168","author":"R Iijima","year":"2013","journal-title":"Int J Cardiol"},{"key":"pone.0227571.ref054","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa071076","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"JV Tu","year":"2007","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T13:52:28Z","timestamp":1578664348000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227571"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Coppola","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227571","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}